From Single Level Analysis to Multi-Omics Integrative Approaches: A Powerful Strategy towards the Precision Oncology
Academic Article
Publication Date:
2018
abstract:
Integration of multi-omics data from different molecular levels with clinical
data, as well as epidemiologic risk factors, represents an accurate and promising
methodology to understand the complexity of biological systems of human diseases,
including cancer. By the extensive use of novel technologic platforms, a large
number of multidimensional data can be derived from analysis of health and
disease systems. Comprehensive analysis of multi-omics data in an integrated
framework, which includes cumulative effects in the context of biological
pathways, is therefore eagerly awaited. This strategy could allow the
identification of pathway-addiction of cancer cells that may be amenable to
therapeutic intervention. However, translation into clinical settings requires an
optimized integration of omics data with clinical vision to fully exploit
precision cancer medicine. We will discuss the available technical approach and
more recent developments in the specific field.
Iris type:
01.01 Articolo in rivista
Keywords:
pharmacogenetics; experimental oncology
List of contributors:
Arbitrio, Mariamena
Published in: